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1. Introduction 
The antiviral drug rifampicin inhibits DNA-depen- 
dent RNA polymerase of E. coli (E.C. 2.7.7.6) in the 
preinitiation phase [l-4] without effecting the act 
of phosphodiester bond formation, responsible for 
the chain growth of the RNA molecules. This proper- 
ty of the drug enabled a detailed study of the mecha- 
nism of the polymerisation reaction in the bacterial 
system. While rifampicin is without influence on the 
RNA polymerase of eukaryotic origin, semi-synthetic 
derivatives of the drug, effecting these enzymes have 
been developed. 
In order to determine the true chain growth rate 
of mammalian polymerases, the foremost prerequisite 
was the verification that the rifampicin derivatives act 
only on the preinitiation stages, without interfering 
with the elongation process. Data indicating that the 
latter condition may be operative were put forward 
by Butterworth et al. [5] and more recently by 
Meilhac et al. [6]. Published data [6] and comparative 
results presented in this report show that derivatives 
exemplify inhibitory potency related to their degree 
of apolarity. 
The present report was adressed to the question 
dealing with the possible effect of semi-synthetic rifam- 
picin derivatives AF/05, AF/O 13 and PR/ 19 on the 
chain growth rates catalysed by RNA polymerases 
from rat liver tissue. 
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2. Materials and methods 
[y-3’ P]ATP and [Y-~* P]GTP, [ 3H]UTP (1 Ci/mmole) 
were obtained from the Radiochemical Centre Amers- 
ham, nucleoside triphosphates, creatine phosphate and 
creatine phosphokinase from Boehringer (Mannheim). 
Rifampicin derivatives AF/OS (3-formyl-rifamycin 
SV:o-(diphenylmethyl) oxim), AF/O13 (3-formyl- 
rifamycin SV:o-rz-octyloxime) and PR/19 (3’-acetyl- 
l’-benzyl-2’-methylpyrrolo 3,2-c-4-deoxy-rifamycin 
SV) were generous gifts of Prof. L.G. Sylvestri (Gruppo 
Lepetit, Milano). All other chemicals used were reagent 
grade obtained from Merck (Darmstadt). 
Nuclear polymerases A and B, and a RNA polymer- 
ase species recently isolated from the cytoplasma of 
the liver cell and designated as C, were isolated and 
purified as described by Seifart et al. [7]. RNA poly- 
merase was measured in an in vitro system, incubated 
for 15 min at 37”, consisting of 0.2 pmoles each of 
ATP, GTP, CTP, 0.05 pmoles of UTP and 1 /Xi 
[ 3 H]UTP. In cases where 5’-termini were labelled by 
[y-3’ P]ATP or -GTP, the concentration of the radio- 
active purine nucleotide was lowered to 0.05 pmole/ 
assay thus adjusting the specific activity to approx. 
1 OOO- 1500 dpm/nmole. In addition, the assay con- 
tained 0.5 pmoles MnS04 (in the case of enzyme A: 
3.0 moles MgS04), 1 mole fl-mercaptoethanol and 
in the case of enzymes B and C, (NH4)a SO,, at an 
ionic strength of 0.2. Each assay contained about 5 
pg enzyme protein in a final volume of 150 d. The 
enzyme, DNA and required ions were mixed and pre- 
incubated for 20 min at 0” to obtain rifampicin resis- 
tant preinitiation complexes, followed by the addition 
of a complete mixture of nucleoside triphosphates. 
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Fig. 1. Inhibitory effect of various concentrations of the rifam- 
picin derivatives on the incorporation of [ 3H]uridine triphos- 
phate into acid insoluble polynucleotides catalysed by rat liver 
polymerase B. ( a-. - - A) AF/OS; (o-o-o) AF/013; 
(o- - -o- - -0) PR/19. In this case the inhibitor was added to the 
enzyme and the reaction started by the addition of all other 
components. 
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Fig. 2. Inhibition of different rat liver RNA polymerases by 
AF/013. Polymerase B was also tested in presence of a stimula- 
tory protein factor [8] enhancing the chain elongation. 
(o- --o- - -0) Polymerase A; (o-o-*) polymerase B without 
E- factor; (o-o-o) B with factor; (A-. - A-. - A) polymerase C. 
At the end of the incubation, aliquots of 120 1.11 were 
pipetted onto filter paper discs (Schleicher u. Schuell, 
2043b paper), fixed and decontaminated in 5% tri- 
chloroacetic acid as described [8]. To remove the re- 
maining antibiotic giving rise to colour-mediated, 
optical quench of varying degree, the decontaminated 
paper discs were additionally washed in acetone- 
diethylether (3: l), followed by 3 rinses in diethylether. 
It is noteworthy that the paper-disc method employed 
yields more reproducible results when compared to 
nitrocellulose filtration in the presence of a carrier, 
possibly due to the lower ultraviolet absorption of 
the non-modified pure cellulose and a lower self-ab- 
sorption of the tritium emissions. 
For the calculation of the average chain length, it 
was assumed that ATP and GTP initiation is equally 
frequent, and that UTP is incorporated at a frequency 
of 25%. Under all conditions, controls from which 
DNA was omitted, were conducted for each experi- 
mental measuring point, in order to reduce error 
arising from DNA independent events. These controls 
were deducted from each value, ensuring that only 
DNA-dependent incorporation values were taken into 
account. 
In those experiments only measuring [ 3 H]UTP 
incorporation, the concentration of both purine nu- 
cleoside triphosphates was 0.2 pmoles/assay and in 
cases assessing the time: temperature requirements for 
the formation of rifampicin resistant complexes, the 
exact experimental conditions are appropriately 
indicated. 
3. Results 
Fig. 1 represents the dose-response curves of the 
rifampicin derivatives AF/O 13, AF/O5 and PR/ 19 on 
RNA synthesis catalysed by rat liver RNA polymerase 
B in vitro. If the drug is allowed to interact with the 
free enzyme, an almost complete degree inhibition is 
observed for AF/Ol3 at 400 pg/ml, allowing only a 
residual synthesis of approx. 5%, whereas this figure 
is approx. 72 and 24% for AF/OS and PR/19, respect- 
ively. These data are somewhat different from those 
presented by Chambon and associates [6] for the calf 
thymus enzymes, who found complete inhibition for 
both derivatives AF/lOS and AF/013. The concentra- 
tion of AF/O13 required to achieve complete inhibition 
31 
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Fig. 3. Effect of preincubating polymerase B with DNA on the 
residual polymerase activity in presence of 400 pg/ml AF/O13. 
Part A: Effect of preincubation temperature. The enzyme and 
native DNA were preincubated for 20 min at 37” (b-. -. - q )j 
18” (A- - - -A), or 0” (o-o). The reaction was then started 
by the addition of a complete mixture of nucleoside triphos- 
phates and required ions. Part B: Effect of preincubation time 
at 0” for 5 (o-o), 10 (A- A) or 20 (a-. - -0) min on the 
residual polymerase activity. 
A 
is higher than communicated by Butterworth et al. [S] 
although these differences are possibly explamed by 
differences in the amount of enzyme employed effect- 
ing the degree of inhibition for simple stoichiometric 
reasons. Subsequent studies were conducted with AF/ 
013, being the most potent inhibitor of DNA-depen- 
dent RNA synthesis. 
Fig. 2 demonstrates, ashasvery recently been shown 
for the enzymes from calf thymus [6], that both nuclear 
enzymes A and B as well as enzyme C are inhibited by 
AF/13. This inhibition is also observed if synthesis of 
enzyme B is conducted in the presence of a stimulatory 
factor from rat liver recently shown to act on the pro- 
cess of chain elongation [8]. 
The crucial question related to these experiments, 
centers on optimizing the conditions of preincubation, 
under which rifamycin resistant binary enzyme:DNA 
complexes are formed. In fig. 3 some of these condi- 
tions are outlined for enzyme B. It is evident that the 
temperature, at which enzyme and DNA are preincu- 
bated for 20 min plays an important role. The time of 
preincubation becomes of lesser importance, when 
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Fig. 4. Effect of different concentrations of AF/O13 on the average chain length of RNA’s synthesized in vitro by nuclear RNA 
polymerase A (part A); polymerase B (part B; (o-o-o) without elongation factor, (X- -X- -X) with elongation factor) and 
cytoplasmic polymerase C (part C). 
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Fig. 5. Time kinetics of the inhibition of different RNA polymerases by 400 pg/ml AF/O13, when the drug is added during enzy- 
matic synthesis. Assays were started by adding a mixture of all components to the enzymes. After 10 min 5 ~1 dimethylformamide 
(o-o-o) or AF/013 in 5 ul DMF (a- - -a- - -A) was added. Part A: nuclear RNA polymerase A; Part B: nuclear RNA polymerase 
B; Part C: cytoplasmic RNA polymerase C [7]. 
conducted between 5 and 20 min (fig. 3 B). 
To elucidate whether these initiation complexes, 
which are formed on DNA and demonstrate apparent 
rifamycin resistance at O’, carry out RNA synthesis 
in a non-perturbed fashion even in the presence of the 
inhibitor, the average chain length of the remaining 
synthesis was calculated and compared to controls. 
The data of fig. 4 convey the conclusion that the 
average chain length of the RNA synthesized by all 
three enzymes after the formation of the binary DNA: 
enzyme complex, decreases as a function of inhibitor 
concentration. It should be pointed out that in the 
control experiments, containing only dimethylforma- 
mide, the average chain length is remarkably short, 
when compared to values estimated for the same en-- 
zymes under identical conditions, but in the absence 
of dimethylformamide [8]. It is conceivable, that the 
lipophilic solvent DMF required to apply the highly 
apolar antibiotics in sufficiently high concentrations, 
also has been an inhibitory action on the chain elong- 
ation process, since experiments have shown (data not 
presented here), that dimethylformamide clearly inhi- 
bits the overall rate of RNA synthesis. 
When AF/Ol3 is added to a system already actively 
engaged in transcription (fig. 5) a much higher propor- 
tion of residual synthesis is resistant to the inhibitor 
compared to its addition to the free enzyme. This is 
a confirmation of previously published data [6]. An 
exact analysis of the time sequence shows however, 
that the inhibition is manifested immediately after the 
addition of inhibitor. 
4. Discussion 
The data presented here demonstrate that rat liver 
RNA polymerases A, B and C can be inhibited by 
rifampicin derivatives PR/ 19, AF/05 and AF/O 13, the 
latter of which shows the highest degree of apolarity 
and highest inhibitory potency on RNA synthesis. 
In their systematic study of the effect of rifampicin 
derivatives on the RNA polymerases from calf thymus, 
which appeared after the experimental part of this 
report had been completed, Meilhac et al. [6] have 
presented a detailed model of transcription analogous 
to that proposed for the bacterial enzyme [9]. Their 
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results demonstrate that the effective derivatives of 
rifampicin completely block the formation of the initi- 
ation complex, when the enzyme is added before the 
formation of the binary DNA:enzyme complex. If prior 
formation of the complex was permitted, addition of 
the apolar rifampicin derivatives caused only a partial 
inhibition of subsequent nucleotide polymerisation. 
The data presented in this report in essence fully 
agree with the conclusions of Chambon and associates 
with respect to the effect of the synthetic rifamycins 
on the inhibition of rat liver RNA polymerases A, B 
and C at the preinitiation stage [6]. However, it has 
been found that these inhibitors, if used at the concen- 
trations employed to achieve complete inhibition of 
free enzyme, may also effect the act of chain elonga- 
tion. It should be pointed out, that if the inhibitor is 
added to a system actively engaged in transcription, 
residual synthesis does occur, reinforcing the previously 
drawn conclusion, that initiated enzyme displays a 
much higher degree of resistance than free enzyme. 
This is in accord with previously published reports. 
However, careful examination of the data shows an 
immediate inhibition of RNA synthesis after addition 
of inhibitor without a phase of complete resistance as 
in the case for E. coli RNA polymerase and rifampicin. 
In this context, the rate of reinitiation obviously be- 
comes of importance since the immediate depression 
of synthesis could obviously reflect the amount of 
reinitiation. It is questionable, however, whether a 
considerable degree of reinitiation occurs with enzyme 
B after 10 min. Taken together with the calculations 
of the average chain length, these data collectively 
indicate, that additional processes, other than the mere 
act of initiation may be impeded by these inhibitors. 
The question of inhibitor concentration is of su- 
preme importance. Fig. 4 shows that concentrations 
up to 40 pg/ml hardly effect the process of chain 
elongation, as has also been reported by Meilhac [6]. 
However, this concentration also does not completely 
inhibit the free enzyme in our hands and considerably 
higher concentrations may then begin to act non-specif- 
ically. Therefore, the balance point, at which these 
compounds can be used as specific inhibitors of initia- 
tion appears to be extremely labile. 
This is an important consideration for the estima- 
tion of parameters like absolute chain growth velocities 
and these findings may be of importance to other inves- 
tigators dealing with related questions. 
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